Literature DB >> 30430194

Deauville score: the Phoenix rising from ashes.

Egesta Lopci1, Michel Meignan2.   

Abstract

Mesh：

Year:  2018        PMID： 30430194     DOI： 10.1007/s00259-018-4215-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  11 in total

1.  Report of the 6th International Workshop on PET in lymphoma.

Authors:  Cristina Nanni; Anne Ségolène Cottereau; Egesta Lopci; Caroline Bodet-Milin; Monica Coronado; Barbara Pro; Wong Seog Kim; Judith Trotman; Sally Barrington; Ulrich Duhrsen; Thierry Vander Borght; Elena Zamagni; Françoise Kraeber-Bodéré; Christina Messiou; Alain Rahmouni; Irène Buvat; Marc Andre; Mark Hertzberg; Wim Oyen; Olivier Casasnovas; Stefano Luminari; Laurent Garderet; Françoise Montravers; Carsten Kobe; Regine Kluge; Annibale Versari; Emanuele Zucca; Philippe Moreau; Bruce Cheson; Corinne Haioun; Andrea Gallamini; Michel Meignan
Journal:  Leuk Lymphoma       Date:  2017-03-07

2.  Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory Hodgkin lymphoma: A series from Lysa centers.

Authors:  Cédric Rossi; Julia Gilhodes; Marie Maerevoet; Charles Herbaux; Franck Morschhauser; Pauline Brice; Sylvain Garciaz; Cécile Borel; Loïc Ysebaert; Lucie Obéric; Julien Lazarovici; Bénédicte Deau; Jehan Dupuis; Adrien Chauchet; Julie Abraham; Fontanet Bijou; Aspasia Stamatoullas-Bastard; Jean-Valère Malfuson; Camille Golfier; Camille Laurent; Sarah Pericart; Alexandra Traverse-Glehen; Salim Kanoun; Thomas Filleron; René-Olivier Casasnovas; Hervé Ghesquières
Journal:  Am J Hematol       Date:  2018-06-08       Impact factor: 10.047

3.  The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.

Authors:  Andrea Gallamini; Sally F Barrington; Alberto Biggi; Stephane Chauvie; Lale Kostakoglu; Michele Gregianin; Michel Meignan; George N Mikhaeel; Annika Loft; Jan M Zaucha; John F Seymour; Michael S Hofman; Luigi Rigacci; Alessandro Pulsoni; Morton Coleman; Eldad J Dann; Livio Trentin; Olivier Casasnovas; Chiara Rusconi; Pauline Brice; Silvia Bolis; Simonetta Viviani; Flavia Salvi; Stefano Luminari; Martin Hutchings
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

4.  18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.

Authors:  Laurent Dercle; Romain-David Seban; Julien Lazarovici; Lawrence H Schwartz; Roch Houot; Samy Ammari; Alina Danu; Véronique Edeline; Aurélien Marabelle; Vincent Ribrag; Jean-Marie Michot
Journal:  J Nucl Med       Date:  2017-06-08       Impact factor: 10.057

5.  PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.

Authors:  Peter Borchmann; Helen Goergen; Carsten Kobe; Andreas Lohri; Richard Greil; Dennis A Eichenauer; Josée M Zijlstra; Jana Markova; Julia Meissner; Michaela Feuring-Buske; Andreas Hüttmann; Judith Dierlamm; Martin Soekler; Hans-Joachim Beck; Wolfgang Willenbacher; Wolf-Dieter Ludwig; Thomas Pabst; Max S Topp; Felicitas Hitz; Martin Bentz; Ulrich Bernd Keller; Dagmar Kühnhardt; Helmut Ostermann; Norbert Schmitz; Bernd Hertenstein; Walter Aulitzky; Georg Maschmeyer; Tom Vieler; Hans Eich; Christian Baues; Harald Stein; Michael Fuchs; Georg Kuhnert; Volker Diehl; Markus Dietlein; Andreas Engert
Journal:  Lancet       Date:  2017-10-20       Impact factor: 79.321

6.  18F-FDG PET/CT for response assessment in Hodgkin lymphoma undergoing immunotherapy with checkpoint inhibitors.

Authors:  Angelo Castello; Fabio Grizzi; Dorina Qehajaj; Daoud Rahal; Fabio Lutman; Egesta Lopci
Journal:  Leuk Lymphoma       Date:  2018-07-22

Review 7.  Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy.

Authors:  Bruce D Cheson; Stephen Ansell; Larry Schwartz; Leo I Gordon; Ranjana Advani; Heather A Jacene; Axel Hoos; Sally F Barrington; Philippe Armand
Journal:  Blood       Date:  2016-08-29       Impact factor: 22.113

8.  Report on the 4th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 3-5 October 2012.

Authors:  Michel Meignan; Sally Barrington; Emmanuel Itti; Andrea Gallamini; Corinne Haioun; Aaron Polliack
Journal:  Leuk Lymphoma       Date:  2013-06-14

9.  Report on the First International Workshop on Interim-PET-Scan in Lymphoma.

Authors:  Michel Meignan; Andrea Gallamini; Michel Meignan; Andrea Gallamini; Corinne Haioun
Journal:  Leuk Lymphoma       Date:  2009-08

Review 10.  International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017).

Authors:  A Younes; P Hilden; B Coiffier; A Hagenbeek; G Salles; W Wilson; J F Seymour; K Kelly; J Gribben; M Pfreunschuh; F Morschhauser; H Schoder; A D Zelenetz; J Rademaker; R Advani; N Valente; C Fortpied; T E Witzig; L H Sehn; A Engert; R I Fisher; P-L Zinzani; M Federico; M Hutchings; C Bollard; M Trneny; Y A Elsayed; K Tobinai; J S Abramson; N Fowler; A Goy; M Smith; S Ansell; J Kuruvilla; M Dreyling; C Thieblemont; R F Little; I Aurer; M H J Van Oers; K Takeshita; A Gopal; S Rule; S de Vos; I Kloos; M S Kaminski; M Meignan; L H Schwartz; J P Leonard; S J Schuster; V E Seshan
Journal:  Ann Oncol       Date:  2017-07-01       Impact factor: 32.976
View more
  2 in total

1.  Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies.

Authors:  Laurent Dercle; Fatima-Zohra Mokrane; Jean Marc Schiano de Colella; Apasia Stamatoullas; Franck Morschhauser; Pauline Brice; Hervé Ghesquières; Olivier Casasnovas; Aiping Chen; Guillaume Manson; Roch Houot
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-19       Impact factor: 9.236

Review 2.  Clinical Perspectives for 18F-FDG PET Imaging in Pediatric Oncology: Μetabolic Tumor Volume and Radiomics.

Authors:  Vassiliki Lyra; Sofia Chatziioannou; Maria Kallergi
Journal:  Metabolites       Date:  2022-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.